Cargando…
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
SIMPLE SUMMARY: Since it was first described over two decades ago, the Alternative Lengthening of Telomeres (ALT) pathway has been well accepted to hold clinical significance in cancer development, cancer diagnosis, and cancer treatment. In this review, first, we discuss how the activation of this p...
Autores principales: | MacKenzie, Danny, Watters, Andrea K., To, Julie T., Young, Melody W., Muratori, Jonathan, Wilkoff, Marni H., Abraham, Rita G., Plummer, Maria M., Zhang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156225/ https://www.ncbi.nlm.nih.gov/pubmed/34069193 http://dx.doi.org/10.3390/cancers13102384 |
Ejemplares similares
-
The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers
por: Watters, Andrea K., et al.
Publicado: (2020) -
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
por: Seltzer, Emily S., et al.
Publicado: (2020) -
G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells
por: Amato, Roberta, et al.
Publicado: (2020) -
Identification of a novel gene fusion in ALT positive osteosarcoma
por: Mason-Osann, Emily, et al.
Publicado: (2018) -
Galerie Alte Meister /
Publicado: (1979)